French Delegation Visits UC Cancer Institute
The UC Cancer Institute hosted a group of 30 delegates from the French Ministry of Health and French academic hospitals on campus Wednesday, March 23, 2011.The group was here to learn about the U.S. model for building a cancer center.
Physicians and researchers affiliated with the UC Cancer Institute presented on topics ranging from translational research (phase 1 trials, brain tumor molecular therapeutics) and the impact a unified cancer center can have on fellowship training to the importance of clinician-scientists who cross the divide between "researcher and "doctor and the role of advanced practice nurses in patient care. UC presenters also highlighted the Cincinnati Cancer Center, collaborative effort of the UC College of Medicine, Cincinnati Childrens Hospital Medical Center and UC Health University Hospital to develop a world-class comprehensive able to provide innovative multidisciplinary cancer research and highly specialized patient care for children and adults in our region.
The French delegation visited three programs in the United Statesthe UC Cancer Institute, MD Anderson and the National Cancer Institute.
UC Cancer Institute French delegation
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.